Employees: 03 (2023.0)Legal category: 5785Size: PMECreation date: 2012-06-28 (13 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-ANDRE-DE-CUBZAC (33240), Gironde
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
LA PHARMACIE DU CENTRE : revenue, balance sheet and financial ratios
LA PHARMACIE DU CENTRE is a French company
founded 13 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-ANDRE-DE-CUBZAC (33240),
this company of category PME
shows in 2022 a revenue of 3.5 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - LA PHARMACIE DU CENTRE (SIREN 752457564)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
N/C
3 514 357 €
N/C
N/C
N/C
N/C
N/C
N/C
Net income
252 834 €
210 562 €
276 566 €
326 636 €
250 802 €
167 128 €
169 757 €
145 938 €
86 407 €
92 192 €
EBITDA
N/C
N/C
N/C
464 120 €
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
9.3%
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, LA PHARMACIE DU CENTRE generates positive net income of 253 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2025: 92 k€ -> 253 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
252 834 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 24%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 66%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
24.251%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
66.105%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution LA PHARMACIE DU CENTRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
296.846
241.331
167.414
113.306
75.84
31.87
27.965
26.878
26.25
24.251
Financial autonomy
23.451
25.852
31.507
40.288
48.76
60.863
64.202
64.456
64.226
66.105
Repayment capacity
None
None
None
None
None
None
1.185
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
9.631%
None%
None%
None%
Sector positioning
Debt ratio
24.252025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Good
In 2025, the debt ratio of LA PHARMACIE DU CENTRE (24.25) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
66.11%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Good
In 2025, the financial autonomy of LA PHARMACIE DU CENTRE (66.1%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 172.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
171.999
Liquidity indicators evolution LA PHARMACIE DU CENTRE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
200.294
128.407
150.356
178.978
167.457
139.609
215.333
204.994
151.686
171.999
Interest coverage
None
None
None
None
None
None
1.499
None
None
None
Sector positioning
Liquidity ratio
172.02025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Average-10 pts over 3 years
In 2025, the liquidity ratio of LA PHARMACIE DU CENTRE (172.00) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 178 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 972 days. Excellent situation: suppliers finance 794 days of the operating cycle (retail model).
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
178 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
972 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution LA PHARMACIE DU CENTRE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Operating WCR
0 €
0 €
0 €
0 €
0 €
0 €
545 042 €
0 €
0 €
0 €
Inventory turnover (days)
0
0
0
0
0
0
28
0
0
0
Customer payment term (days)
0
0
0
0
0
0
6
0
188
178
Supplier payment term (days)
0
0
0
0
0
0
37
0
968
972
Positioning of LA PHARMACIE DU CENTRE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of LA PHARMACIE DU CENTRE is estimated at
4 016 298 €
(range 2 725 478€ - 6 302 124€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
2725k€4016k€6302k€
4 016 298 €Range: 2 725 478€ - 6 302 124€
NAF 5 année 2025
Valuation method used
Net Income Multiple
252 834 €
×
15.9x
=4 016 298 €
Range: 2 725 479€ - 6 302 125€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare LA PHARMACIE DU CENTRE with other companies in the same sector:
Frequently asked questions about LA PHARMACIE DU CENTRE
What is the revenue of LA PHARMACIE DU CENTRE ?
The revenue of LA PHARMACIE DU CENTRE in 2022 is 3.5 M€.
Is LA PHARMACIE DU CENTRE profitable?
Yes, LA PHARMACIE DU CENTRE generated a net profit of 253 k€ in 2025.
Where is the headquarters of LA PHARMACIE DU CENTRE ?
The headquarters of LA PHARMACIE DU CENTRE is located in SAINT-ANDRE-DE-CUBZAC (33240), in the department Gironde.
Where to find the tax return of LA PHARMACIE DU CENTRE ?
The tax return of LA PHARMACIE DU CENTRE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does LA PHARMACIE DU CENTRE operate?
LA PHARMACIE DU CENTRE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart